- Jiyya
- Shaidun
- Neuroblastoma
- Ciwon daji mai ƙarfi
- Shaidun
- TILS
- Maganin Kwayoyin NK
- Myasthenia Gravis (MG)
- Ciwon sankarar lymphoblastic mai tsanani (B-ALL)
- Tsarin Lupus Erythematosus (SLE)
- Ciwon sankarar lymphoblastic mai tsanani (T-ALL)
- Lymphoma na Non-Hodgkin (NHL)
- Myeloma da yawa (MM)
- Babban Lymphom na B-cell da aka Yaɗu
- B-lymphocytic Leukemia
- Myeloma
Junaid---Cute B-lymphocytic Leukemia (B-ALL)
Gwajin asibiti na CAR-T na dashen ƙashi na gada ya sa marasa lafiya marasa lafiya marasa lafiya marasa lafiya B-ALL ba su da cutar a BIOOCUS Medical Group.
Shekaru biyar da suka gabata, Junaid ɗalibi ne a Jami'ar Likitanci ta Pakistan, cike da burin zama likita. Amma a watan Mayu na 2014, an gano yana da cutar sankarar jini ta B-lymphocytic kuma dole ne ya daina karatunsa.
An yi masa magani a gida fiye da shekaru biyu. A watan Janairun 2018, ya sake samun ciwon ƙashi na jiki kuma gwajin ƙashi ya nuna cewa ya sake komawa. Bayan gwajin chemotherapy na biyu a asibiti na yankin, bai sami sauƙi ba kuma cutar ta ci gaba. Ta hanyar binciken intanet da shawarwarin wasu marasa lafiya, sun yanke shawarar zuwa cibiyarmu ta CGT don gwajin asibiti na CART da BMT.
A ranar 26 ga Maris 2018, Junaid da iyalinsa suka zo China kuma aka kwantar da su a sashen kula da cututtukan jini na gaba ɗaya. Dr ya gudanar da cikakken bincike kan Junaid. Rahotanni sun nuna cewa yawan fashewar ƙashi ya kai kashi 69% kuma yana da cututtukan fungal na huhu. Bayan an yi masa magani mai kyau, majinyacin yana cikin koshin lafiya. A ranar 24 ga Afrilu 2018, an sake saka wa Junaid ƙwayoyin CAR-T guda biyu na CD19 da CD22. Bayan makonni biyu, adadin ƙwayoyin fashewar ƙashi ya kai 0. Murmushi ya dawo wa iyalan Junaid. Za a yi wa Junaid gwajin cutar BMT don ya warke daga cutar.
A ranar 25 ga Yuni 2018, sashen BMT Dr ya yi wa Junaid BMT ɗan'uwa. Mai ba da gudummawar ga Junaid ƙaninsa ne. A ranar 6 ga Yuli, an sake saka ƙwayar halittar jini ta gefen mai ba da gudummawar cikin Junaid, bayan kwana 17 an kammala dashen ƙwayoyin jinin farin jini kuma ya ƙaura daga sashen kwararar jini na laminar. Bayan kwana 24, nau'in ɓawon ƙashi nasa ya yi daidai da nau'in ɓawon ƙashi na mai ba da gudummawar. Binciken rahoton ragowar ɓawon ƙashi ba shi da kyau, ba tare da wata matsala da ta shafi dashen farko ba. A ranar 6 ga Agusta 2018, an sallami Junaid daga asibiti kuma ya fara bin diddigin marasa lafiya a waje.
Ƙungiyar jinin ƙasar Sin ita ce babbar goyon bayan majiyyacin. Junaid nau'in jini ne mai kama da RH, wanda nau'in jini ne mai wuya. Ya karɓi kyautar jini kyauta "Lang Fang rare blood type alliance" sau da yawa a lokacin da yake kwance a asibiti. Bai taɓa zama kamar ƙarancin jijiyoyi a gare shi ba, Junaid da iyalinsa suna matuƙar godiya ga cibiyar duniya da ta yi wa Junaid duk waɗannan abubuwan. A halin yanzu, ma'aikatan cibiyar ta ƙasa da ƙasa sun raka Junaid da iyalinsa tun daga lokacin da suka sauka har zuwa yanzu, sun ba su dukkan goyon bayan rayuwa kuma sun taimaka wa iyalin wajen shawo kan matsalar harshe.
Gwajin asibiti na CAR-T ya haɗa BMT don ƙirƙirar wani abin al'ajabi. Junaid shine majiyyaci na biyu da ya sake dawowa kuma ya yi fama da cutar sankarar jini ta B-lymphocytic daga Pakistan da ya sami maganin CAR-T Bridge BMT. Nasarar da Junaid ya samu daga asibiti ta sake nuna amincewar duniya da fasahar zamani ta dashen gadar CAR-T da asibitinmu ya yi.
bayanin2
Submit An Free Inquiry
Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

